http://orcid.org/0000-0002-5117-2502
References
- [cited 2016 Dec 17]. Available from: http://publications.iarc.fr/Non-Series-Publications/World-Cancer-Reports/World-Cancer-Report-2014.
- [cited 2016 Dec 17]. Available from: http://www.who.int/mediacentre/factsheets/fs297/en/.
- [cited 2016 Dec 17]. Available from: http://www.who.int/nmh/publications/ncd-status-report-2014/en/.
- Simmons VN, Pineiro B, Hooper MW, et al. Tobacco-related health disparities across the cancer care continuum. Cancer Control. 2016;23:434–441.
- Carroll AJ, Labarthe DR, Huffman MD, et al. Global tobacco prevention and control in relation to a cardiovascular health promotion and disease prevention framework: a narrative review. Prev Med. 2016;93:189–197.
- O’Keefe JH, Bhatti SK, Bajwa A, et al. Alcohol and cardiovascular health: the dose makes the poison … or the remedy. Mayo Clin Proc. 2014;89:382–393.
- Simon TG, Corey KE, Chung RT, et al. Cardiovascular risk reduction in patients with nonalcoholic fatty liver disease: the potential role of ezetimibe. Dig Dis Sci. 2016;61:3425–3435.
- Ahmed SH, Moussa Sherif DE, Fouad Y, et al. Principles of a risk evaluation and mitigation strategy (REMS) for breast cancer patients receiving potentially cardiotoxic adjuvant treatments. Expert Opin Drug Saf. 2016;15:911–923.
- Abdel-Rahman O, Alorabi M. Use of angiotensin-converting enzyme inhibitors in the prophylaxis of anthracycline or trastuzumab-related cardiac dysfunction: preclinical and clinical considerations. Expert Rev Anticancer Ther. 2015;15:829–837.
- Abdel-Rahman O. Causes of death in long-term lung cancer survivors: a SEER database analysis. Curr Med Res Opin. 2017;1-16.
- Surveillance, Epidemiology and End Results Program. About the SEER Program. [2017 Jul 2]. Available at: http://seer.cancer.gov/about.
- Maas A, Appelman YEA. Gender differences in coronary heart disease. Neth Heart J. 2010;18:598–602.
- Rivera MP. Lung cancer in women: differences in epidemiology, biology, histology, and treatment outcomes. Semin Respir Crit Care Med. 2013;34:792–801.
- Jolly S, Vittinghoff E, Chattopadhyay A, et al. Higher cardiovascular disease prevalence and mortality among younger blacks compared to whites. Am J Med. 2010;123:811–818.
- Lin SH, Zhang N, Godby J, et al. Radiation modality use and cardiopulmonary mortality risk in elderly patients with esophageal cancer. Cancer. 2016;122:917–928.
- Park HS, Harder EM, Mancini BR, et al. Central versus peripheral tumor location: influence on survival, local control, and toxicity following stereotactic body radiotherapy for primary non-small-cell lung cancer. J Thorac Oncol. 2015;10:832–837.
- Ye JC, Yan W, Christos P, et al. Second cancer, breast cancer, and cardiac mortality in stage T1aN0 breast cancer patients with or without external beam radiation therapy: a national registry study. Clin Breast Cancer. 2015;15:54–59.
- Pugh TJ, Ballonoff A, Rusthoven KE, et al. Cardiac mortality in patients with stage I and II diffuse large B-cell lymphoma treated with and without radiation: a surveillance, epidemiology, and end-results analysis. Int J Radiat Oncol Biol Phys. 2010;76:845–849.
- Hubbard MO, Fu P, Margevicius S, et al. Five-year survival does not equal cure in non–small cell lung cancer: a surveillance, epidemiology, and end results–based analysis of variables affecting 10- to 18-year survival. J Thorac Cardiovasc Surg. 2012;143:1307–1313.
- Halanych JH, Shuaib F, Parmar G, et al. Agreement on cause of death between proxies, death certificates, and clinician adjudicators in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Am J Epidemiol. 2011;173:1319–1326.
- Asnaes S, Frederiksen V, Fenger C. The value of the hospital autopsy. A study of causes and modes of death estimated before and after autopsy. Forensic Sci Int. 1983;21:23–32.
- Masocco M, Kodra Y, Vichi M, et al. Mortality associated with neurofibromatosis type 1: a study based on Italian death certificates (1995-2006). Orphanet J Rare Dis. 2011;6:11.